CN109275914A - Black fungus polypeptide function edible composition and its preparation method and application - Google Patents
Black fungus polypeptide function edible composition and its preparation method and application Download PDFInfo
- Publication number
- CN109275914A CN109275914A CN201811091421.4A CN201811091421A CN109275914A CN 109275914 A CN109275914 A CN 109275914A CN 201811091421 A CN201811091421 A CN 201811091421A CN 109275914 A CN109275914 A CN 109275914A
- Authority
- CN
- China
- Prior art keywords
- black fungus
- enzyme
- ginger
- jujube
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 116
- 241000233866 Fungi Species 0.000 title claims abstract description 88
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 title claims abstract description 62
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 14
- 235000008397 ginger Nutrition 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 102000004190 Enzymes Human genes 0.000 claims description 66
- 108090000790 Enzymes Proteins 0.000 claims description 66
- 241001247821 Ziziphus Species 0.000 claims description 35
- 102000004169 proteins and genes Human genes 0.000 claims description 31
- 108090000623 proteins and genes Proteins 0.000 claims description 31
- 108091005804 Peptidases Proteins 0.000 claims description 28
- 239000004365 Protease Substances 0.000 claims description 25
- 239000000796 flavoring agent Substances 0.000 claims description 23
- 235000019634 flavors Nutrition 0.000 claims description 23
- 239000002994 raw material Substances 0.000 claims description 22
- 239000000284 extract Substances 0.000 claims description 19
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 16
- 235000019419 proteases Nutrition 0.000 claims description 16
- 235000013305 food Nutrition 0.000 claims description 14
- 241000234314 Zingiber Species 0.000 claims description 13
- 102000035195 Peptidases Human genes 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 10
- 229940002508 ginger extract Drugs 0.000 claims description 10
- 235000020708 ginger extract Nutrition 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 6
- 235000019833 protease Nutrition 0.000 claims description 6
- 108091008146 restriction endonucleases Proteins 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 238000002203 pretreatment Methods 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 1
- 235000015895 biscuits Nutrition 0.000 claims 1
- 238000005119 centrifugation Methods 0.000 claims 1
- 230000005484 gravity Effects 0.000 claims 1
- 239000007937 lozenge Substances 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 239000002023 wood Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 12
- 230000009471 action Effects 0.000 abstract description 8
- 238000002474 experimental method Methods 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000035622 drinking Effects 0.000 abstract description 3
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 230000010354 integration Effects 0.000 abstract description 2
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 63
- 229940088598 enzyme Drugs 0.000 description 54
- 230000006870 function Effects 0.000 description 41
- 210000004369 blood Anatomy 0.000 description 35
- 239000008280 blood Substances 0.000 description 35
- 238000012360 testing method Methods 0.000 description 29
- 235000018102 proteins Nutrition 0.000 description 27
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 25
- 239000000523 sample Substances 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 238000000034 method Methods 0.000 description 21
- 239000000047 product Substances 0.000 description 21
- 239000000243 solution Substances 0.000 description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 16
- 230000003750 conditioning effect Effects 0.000 description 16
- 239000008103 glucose Substances 0.000 description 16
- 230000036541 health Effects 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 238000001514 detection method Methods 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 238000010200 validation analysis Methods 0.000 description 13
- 235000012000 cholesterol Nutrition 0.000 description 12
- 240000006439 Aspergillus oryzae Species 0.000 description 10
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 230000007062 hydrolysis Effects 0.000 description 9
- 238000006460 hydrolysis reaction Methods 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000012795 verification Methods 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 230000001629 suppression Effects 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 108090000526 Papain Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 210000002540 macrophage Anatomy 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 244000189799 Asimina triloba Species 0.000 description 5
- 235000006264 Asimina triloba Nutrition 0.000 description 5
- 235000009467 Carica papaya Nutrition 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 238000005251 capillar electrophoresis Methods 0.000 description 5
- 235000001727 glucose Nutrition 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 230000000242 pagocytic effect Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- 229910001415 sodium ion Inorganic materials 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 108091005508 Acid proteases Proteins 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- 208000029549 Muscle injury Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 244000126002 Ziziphus vulgaris Species 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 229940100688 oral solution Drugs 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 108010004032 Bromelains Proteins 0.000 description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 235000019835 bromelain Nutrition 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 230000004130 lipolysis Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000000116 mitigating effect Effects 0.000 description 3
- 238000009928 pasteurization Methods 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 235000020097 white wine Nutrition 0.000 description 3
- 235000014101 wine Nutrition 0.000 description 3
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241001269238 Data Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 2
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- 108090000783 Renin Proteins 0.000 description 2
- 102100028255 Renin Human genes 0.000 description 2
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- -1 carrotene Proteins 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 229940099352 cholate Drugs 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 239000000893 inhibin Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000005374 membrane filtration Methods 0.000 description 2
- 230000007102 metabolic function Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000001223 reverse osmosis Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000009758 senescence Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000005495 thyroid hormone Substances 0.000 description 2
- 229940036555 thyroid hormone Drugs 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000009461 vacuum packaging Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 238000001238 wet grinding Methods 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZDLZKMDMBBMJLI-FDMDGMSGSA-N 2-[[2-[[(2s)-2-[[(e)-3-(furan-2-yl)prop-2-enoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]acetic acid Chemical compound C([C@@H](C(=O)NCC(=O)NCC(=O)O)NC(=O)\C=C\C=1OC=CC=1)C1=CC=CC=C1 ZDLZKMDMBBMJLI-FDMDGMSGSA-N 0.000 description 1
- 108010048632 2-furanacryloyl-phenylalanyl-glycyl-glycine Proteins 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 240000005611 Agrostis gigantea Species 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000150786 Athletes Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- CSSZPOBBUXFMAA-UGLFEJFNSA-N Penupogenin Natural products C[C@H](O)[C@]1(O)CC[C@]2(O)[C@@]3(O)CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3C[C@@H](OC(=O)C=Cc5ccccc5)[C@@]12C CSSZPOBBUXFMAA-UGLFEJFNSA-N 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710089165 Protein white Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000221365 Tremellales Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000003486 adipose tissue brown Anatomy 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- XKMRRTOUMJRJIA-UHFFFAOYSA-N ammonia nh3 Chemical compound N.N XKMRRTOUMJRJIA-UHFFFAOYSA-N 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 239000002416 angiotensin derivative Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002075 anti-alcohol Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000285940 beete Species 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000011222 chang cao shi Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000008828 contractile function Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000019256 formaldehyde Nutrition 0.000 description 1
- 229960004279 formaldehyde Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000001448 refractive index detection Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000032895 transmembrane transport Effects 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/06—Products with modified nutritive value, e.g. with modified starch content
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/245—Amino acids, nucleic acids
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/36—Vegetable material
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/347—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of proteins from microorganisms or unicellular algae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of compositions and its preparation method and application for keeping object mixing preparation pair in mind comprising black fungus polypeptide, jujube and ginger.The composition main composition is black fungus micromolecule polypeptide, is easy to absorb, and Efficacy experiments prove that the treatment to a variety of subhealth symptoms has good booster action.The constitutive material of composition is from a wealth of sources, integration of drinking and medicinal herbs, has good market application prospect.
Description
Technical field
The invention belongs to technical field of food science, it is related to the function edible composition that a kind of plant is raw material, more
Body is related to a kind of function edible composition and preparation method thereof of extract of complex polypeptide containing black fungus.
Background technique
With world economy high speed development, social rhythm increasingly accelerates, and psychological pressure continues to increase, and environmental pollution damage is tight
Weight, causes majority to be in sub-health state, in terms of there is psychoneural aspect, treating cardiac and cerebral vascular diseases, digestive system and moves
The activity that system aspects are related to multiple systems deviates normal condition.When human body is in sub-health state, on cellular level, show as
Na+, K+-ATP enzymatic activity are suppressed on cell membrane or inactivate, and are not able to satisfy the exchange of intraor extracellular potassium, sodium ion, influence film electricity
Position and cause contractile function to reduce;The molecules transmembrane transports such as glucose, fatty acid and lactic acid are reduced, endocellular metabolism function is influenced
Can, hinder on film ion exchange, reduction Na+, Ca2+-ATP inside and outside H+ and the films such as lactate transhipment, Cl-/HCO3-, Na+/H+
Enzymatic activity makes Ca2+ conveying be obstructed, and superoxide radical increases, and changes polypeptide, configuration of catecholamine hormone receptor etc. on film
Deng eventually leading to the generation and development of various diseases so as to cause the sub-health state of human body.Sub-health state seriously affects
People's lives quality affects our work and cause.Improve inferior health constitution and reverts to health status as the whole world
And the important health care demand in China.
Although there is the product of the improvement inferior health constitution of a multitude of names on the market at present, most expensive starting materials have
Preparation process it is complicated, some tastes are bad, and the design feature and product component system of some product components cause the product to inhale
The symptom index that rate of producing effects is undesirable, conditioning is improved is few.In short, in the function edible composition technical field of Subhealth treating,
, there is still a need for continually developing raw material to be easy to get, simple process is in good taste for we, and absorption efficiency is high, improves more than symptom type
Healthcare function product.
Black fungus is China's Subhealth treating food materials important since ancient times.Containing colloid protein and water-soluble fibre, black wood
Ear colloid albumen and water-soluble fibre can clear up enteron aisle rubbish, increase intestines peristalsis, treat constipation, for cleaning blood vessel and clearly
Except lung's rubbish has remarkable result.It is the health care product of the improvement inferior health of the dust pollutions industries such as haircut production, textile worker.But
The black fungus of edible routine form is unfavorable for intestinal absorption, and eating human absorptivity as vegetable is only 5-8%.
Modern nutriology has many physiology function the study found that plant polypeptide is lower-molecular substance important in organism
Can, in addition to the precursor as RNA, DNA, also as Biochemical processes Auto-regulator participate in vivo be metabolized, eucaryotic cell structure,
It plays an important role in terms of metabolism and regulatory function.Therefore black fungus polypeptide is then a kind of important Subhealth treating polypeptide.
There is jujube QI invigorating to support kidney, blood-enriching face-nourishing, tonifying liver decompression, soothing nerves, tonifying yang, control the effect of consumptive disease damage." therefore jujube is pole
Good tonic food.Li Shizhen (1518-1593 A.D.) is said in Compendium of Material Medica [1]: jujube is sweet in flavor, warm-natured, and energy tonifying middle-Jiao and Qi, nourishes blood and promotes the production of body fluid are used for
The diseases such as treatment " spleen deficiency weak, anorexia and loose stool, deficiency of qi and blood ".It is recorded in the herbal medicine books " this warp " of China, jujube property sweet in flavor
Temperature, returns spleen stomach meridian have tonifying middle-Jiao and Qi, nourishing blood and tranquilization, the function of mitigating pharmacological property;And modern pharmacology then finds that jujube contains
The nutritions abundant such as protein, carbohydrate, organic acid, vitamin A, vitamin C, lot of trace calcium and amino acid, jujube energy
It improves the immunity of the human body, and can inhibit cancer cell.Pharmacological research discovery, jujube can promote the generation of leucocyte, reduce serum gallbladder
Sterol improves seralbumin, protects liver, also contains in jujube and inhibit cancer cell, or even cancer cell can be made to normal cell
The substance of conversion.Rutin contained by jujube can make angiomalasia, to reduce blood pressure, have prophylactic-therapeutic effect to high blood pressure.Jujube is rich
Containing the ingredients such as protein, fat, carbohydrate, carrotene, B family vitamin, vitamin C, citrin and phosphorus, calcium, iron, wherein tieing up
The content of raw element C comes out at the top in fruit, there is the laudatory title of " natural vitamin ball ".With stronger tonic effect, can improve
Immune function of human body enhances disease resistance;Containing flavones -- double-glycoside A has calm, hypnosis and antihypertensive effect, wherein shaddock
Aglycon C glucoside has central inhibitory action, i.e. reduction autogenic movement and stimulation reflex, tetanic numb effect, therefore jujube has
There is the function of tranquilizing the mind, calmness;The cyclic adenosine monophosphate being rich in is the necessary material of human energy metabolism, can enhance muscular strength, eliminate it is tired
Labor, increases myocardial contractive power, improves myocardial nutrition expansion blood vessel, has good effect to prevention and cure of cardiovascular disease.Jujube has
Tonic and nourishing, nourishing blood and tranquilization, strengthening the spleen and stomach and other effects.Jujube is to diseases such as acute, chronic hepatitis, cirrhosis, anaemia, anaphylactoid purpuras
There is good therapeutic effect.Jujube contains triterpene compound and cyclic adenosine monophosphate, there is stronger suppression cancer, anti-allergic effects, to prevention and treatment bone
Matter is loose, postpartum anemia plays an important role.
(3) the effect of ginger: cardiac stimulus and blood vessel
Rich in gingerol, there is certain stimulation to heart and blood vessel, palpitating speed, blood vessel dilatation can be made, to make
Channels is unobstructed, and supply is normal.
In Subhealth treating function edible composition field, not yet occur commercialized including black fungus polypeptide, and compound
The complex function edible composition composition of jujube and ginger effective active composition.
Summary of the invention
Deficiency that is existing and seeming is made up the object of the present invention is to provide a kind of, a kind of raw material is easy to get, simple process,
In good taste, absorption efficiency is high, and the function comprising black fungus complex polypeptide of improving the improvement inferior health more than symptom type eats group
Close object and preparation method thereof and medical usage.
For achieving the above object, a technical solution of the invention is a kind of function edible composition, and it includes black
Agaric polypeptide extract, Fructus Jujubae extract and Ginger P.E.Wherein, the black fungus polypeptide, Ginger P.E and jujube mention
The weight ratio for taking object is 10~20 parts: 30~60 parts: 5~10 parts.
Wherein, the weight ratio of the black fungus polypeptide, Fructus Jujubae extract and Ginger P.E is 10~20 parts: 30
~60 parts: 5~10 parts.
Second scheme of the invention is kind of the function comprising black fungus polypeptide extract, Fructus Jujubae extract and Ginger P.E
The preparation method of energy edible composition, compound protease decompose black fungus raw material and obtain black fungus complex polypeptide enriched product, match
With jujube and Ginger P.E, the function and service object for improving human-body sub-health is made.Preparation method includes: processing homogenate, carefully
Born of the same parents are broken, digest, and extract filtering, add jujube, ginger extract in proportion, dry after mixing, must can be used for Subhealth treating
Function composition dry powder formulations.Including step
(1) black fungus small-molecular peptides solution is prepared;
(2) jujube and ginger mixed extract are prepared respectively;
(3) by black fungus small-molecular peptides solution, jujube extracting solution and ginger extract according to 10~20 parts::
30~60 parts: 5~10 of weight ratio mixing preparation;
(4) mixture drying is formed into powder mixture.
(5) using step (4) resulting powder mixture as additive, function edible composition is prepared.
In one embodiment, the function edible composition is oral solution.
In one embodiment, the step (5) includes such as colored, filling, pasteurization, labeling.
In some embodiments, in the step (2) jujube extracting solution extracting method comprising steps of cleaning, cleaning,
Thermophilic digestion, mashing, filtering, colloid mill, homogenate.
In some embodiments, in the step (2) ginger extract extracting method comprising steps of cleaning, juicing,
Filtering.
In some embodiments, the compound small-molecular peptides of the black fungus preparation method comprising steps of
Pre-treatment
(1) physics is broken;
(2) pyrohydrolysis;
(3) it is homogenized;
(4) it sterilizes;
Digest black fungus polypeptide
(4) compound protease, heat preservation hydrolysis are added;
(5) it is centrifuged, separation and fermentation liquid;
Drying and moulding and packing
(6) it is spray-dried;
(7) it pelletizes, packing.
In some embodiments, the sieving is that the black fungus after Mechanical Crushing is crossed 20~60 meshes.
In a specific embodiment, the sieving is that the black fungus after Mechanical Crushing is crossed 35 meshes.
In some embodiments, the temperature of the pyrohydrolysis is 80 to 100.
In one embodiment, the temperature of the pyrohydrolysis is 100.
In some embodiments, the temperature of the pyrohydrolysis is 80 to 100
In some embodiments, the time of the pyrohydrolysis is 1 to 6 hours.
In a specific embodiment, the time of the pyrohydrolysis is 3 hours.
In some embodiments, the homogenate is that the black fungus after pyrohydrolysis acts on 0.5 in grinding homogenate equipment
~2 hours.
In a specific embodiment, the homogenate is that the black fungus after pyrohydrolysis acts on 1 in grinding homogenate equipment
Hour.
In a specific embodiment, the compound small-molecular peptides of the black fungus be decomposed by compound protease it is pretreated
Broken agaric obtain.
Efficient proteolytic enzyme should have other than answering percent hydrolysis with higher to substrate protein white matter using peace
Entirely, cheap, the features such as working condition is of less demanding.Enzyme is as a kind of with physiological activity
Specific proteins, active centre is different, and the corresponding specificity that hydrolyzes is also different, selects not to same protein
Same protease is hydrolyzed, and hydrolysis effect has very big difference.Different according to the pH scope of application, test uses neutral protein
Two kinds of enzyme united hydrolysis of enzyme and acid protease, to obtain high percent hydrolysis.
In some embodiments, the proteinase complex includes albumen excision enzyme, protein incision enzyme and food flavor enzyme.
In some embodiments, the protease includes animal origin, plant origin and microbe-derived.
The protease of the animal origin includes trypsase, pepsin and chymotrypsin;The plant origin
Protease include papain, bromelain and ficin;The microbe-derived protease includes type
Bacillus 2709, actinomyces 166, rare earth aspergillus 3.942, As1.389 and As3.350.
In some embodiments, the protein incision enzyme is in comprising papain, bromelain, 1.39
The group of property protease, 2709 alkali proteases and acid protease.
In some embodiments, the albumen excision enzyme, which is selected from, includes aspergillus oryzae excision enzyme, aspergillus niger excision enzyme and rice
The group of bent black bent excision enzyme.
In some embodiments, the food flavor enzyme includes yeast flavor enzyme, lactic acid bacteria food flavor enzyme and hay bacillus flavor
Enzyme.
In some embodiments, the proteinase complex is selected from pawpaw restriction endonuclease, bromelain, 1.398 neutrality
It is two or more in protease, 2709 alkali proteases, acid protease, aspergillus oryzae excision enzyme and yeast flavor enzyme.
In some embodiments, the proteinase complex is by aspergillus oryzae excision enzyme, pawpaw restriction endonuclease and yeast flavor
Enzyme composition.
Concentration of substrate, enzyme concentration, hydrolysis temperature, pH value, the condition appropriate such as time be influence hydrolysis result it is main because
Element.
In some embodiments, the Mole percent composition ratio of the pawpaw restriction endonuclease and yeast flavor enzyme is 1:10
~10:1.
In some embodiment party examination, the dosage of the aspergillus oryzae excision enzyme is 1000U/g, the dosage of the pawpaw restriction endonuclease
For 1000U/g, the dosage of the food flavor enzyme is 100U/g.
In a specific embodiment, the Mole percent composition ratio of the pawpaw restriction endonuclease and yeast flavor enzyme is 4:
4:2。
In some embodiments, it includes circumscribed enzyme effect that the proteolytic enzyme complex hydrolyses black fungus, which is homogenized, interior
Enzyme cutting effect.
In some embodiments, the proteolytic enzyme complex hydrolyses black fungus homogenate further includes food flavor enzyme three steps
Suddenly.
In some embodiments, the circumscribed enzyme action time is 6~20 hours, and the inscribe enzyme action time is 20
~100 hours, the flavor enzyme action time was 10~20 hours.
In some embodiments, the circumscribed enzyme action time is 12 hours, and the inscribe enzyme action time is 60 small
When, the flavor enzyme action time is 15 hours.
In some embodiments, the effect pH value of the protein incision enzyme is 6.0~7.0.
In one embodiment, the effect pH value of the protein incision enzyme is 6.5.
In some embodiments, the operative temperature of the albumen excision enzyme is 50 degree to 60 degree.
In some embodiments, the operative temperature of the protein incision enzyme is 50 degree to 60 degree.
In some embodiments, the operative temperature of the albumen food flavor enzyme is 50 degree to 60 degree.
In some embodiments, the heating method is steam heating.
In some embodiments, the heating method is microwave heating.
In some embodiments, the additional amount of the albumen excision enzyme is the every 200g black fungus of 30`80g protease.
In some embodiments, the compound small-molecular peptides of the black fungus are to ferment to obtain by composite bacillus.?
In one embodiment, the bacillus compound bacteria is made of bacillus subtilis and bacillus licheniformis, and the spore bacillus is multiple
The thallus number ratio of careless bacillus and bacillus licheniformis in combined bacteria is 1::10~10:1.
Bacillus subtilis is the widely applied a kind of bacteriums in fields such as industry, agricultural and medical industry, neutral proteinase
A kind of important products raw as producing bacillus subtilis, the application in food-processing industry increasingly causes people in recent years
Pay attention to.Bacillus cereus is a kind of critical strain for generating alkali protease.
Black fungus homogenate obtains polypeptide product after enzymatic hydrolysis to be had since the physicochemical property of black fungus includes
1) low viscosity under good dissolubility and high concentration;
2) good and acidproof and heat-resistant stability;
3) black fungus polypeptide Instant is good, and NS1 value is up to 85%.;
4) black fungus polypeptide has good hygroscopicity, moisture retention and gel softening function.These good reasons
Changing characteristic is that black fungus polypeptide has the high property digested and assimilated, high antioxidant, low antigenicity, has protection and improves
The multiple functions such as function of human body, skin care.Third technical solution of the invention is that polypeptide extract containing black fungus, jujube mention
Take application of the function and service object of object and Ginger P.E in conditioning subhealthy state symptom.
In some embodiments, the effect of the conditioning subhealthy state includes
1, active absorption restores rapidly physical efficiency
Human body just needs to consume the amino acid in muscle when carrying out vigorous exercise in order to feed energy.That is body
It needs to obtain from muscle when energy.After amino acid in muscle is consumed, musculature will be damaged,
Muscle generates feeling of fatigue, is difficult to play original strength.Active peptide can more quickly be absorbed by the body than amino acid.Restoring body
In terms of power, active peptide also plays excellent effect.
In some embodiments, the effect of the conditioning subhealthy state includes
2, brain fag is eliminated
Caused by brain fag is the rising as oxygenated haemoglobin concentration, taking agaric active peptide can inhibit to aoxidize blood
The rising of hemoglobin concentration, it is thus possible to mitigate the stress of brain.
In some embodiments, the effect of the conditioning subhealthy state includes accelerating lipolysis:
Peptide has the function of hindering fat absorption, accelerates lipolysis, promotes basic metabolism, can increase energy after diet
Consumption, promote body fat burning.After the intake of black fungus oligopeptide, blood is rapidly entered, sporter can be met to albumen
The metabolic demand of matter prevents muscle, skin, blood etc. because of the generation of movement consumption albumen, muscle damage phenomenon.Active peptide can be with
It solves the problems, such as " supplementing protein within the growth hormone secretion vigorous period ", there is quick, entirety to be absorbed function
Feature
In some embodiments, the effect of the conditioning subhealthy state includes mitigating to move caused muscle damage
Active peptide is compared with amino acid, and faster by the speed of intestinal absorption, edible jelly fungi peptide can be rapid after movement for active peptide
Ground supplement protein, the muscle damage as caused by SRT load and resulting myalgia, swelling are all substantially reduced.Pass through
The continuous repetition of circulation, muscle will become more and more strongr.
In some embodiments, the effect of the conditioning subhealthy state includes adjusting blood lipid, norcholesterol
After taking in active peptide, the intracorporal thyroid body of people can be stimulated, increases thyroid hormone secretion amount.Thyroid hormone
It is external to have the function of that the acidification of promotion cholesterol, obstruction intestinal wall accelerate to exclude to cholesterol absorption.Active peptide is for reducing people
Body cholesterol has selection index system characteristic, and when body's cholesterol is under normal state of value, intake active peptide is to cholesterol without drop
Inefficient to answer, after high cholesterol patient takes in small-molecular peptides, then generating cholesterol reduces effect, and reduced Lipoprotein classes category
It is beneficial to human body, blood lipid molecule can be carried decomposed to liver, exclude body in the low-density lipoprotein being harmful to the human body
Outer high-density lipoprotein effect.Active peptide can increase the activity of mitochondria inside brown fat, promote fat metabolism.It can also increase
Add the conversion ratio of norepinephrine, the inhibition to lipase is reduced, to promote fat metabolism.Take in black fungus small molecule
Peptide can also play the role of preventing serum cholesterol and blood lipid raised.Show in the culture experiment made of enterocyte: active peptide
Pass through the DNA structure for invading cholesterol cell, destroying cholesterol, it is suppressed that the proliferation of cholesterol.
In some embodiments, the effect of the conditioning subhealthy state includes improving the effect of immunity
Contain the amino acid that immunity can be improved in active peptide.It is wherein representative to be exactly: arginine and paddy ammonia
Acid.The immune function of the macrophage cell in immunocyte can be enhanced in arginine, while attacking invading virus.In addition,
When a large amount of Virus entry human bodies, glutamic acid can produce immunocyte, beat back virus.So active peptide can improve machine
The cellular immune function of body, it can promote T lymphocyte to be proliferated, and enhance the function of macrophage, enhance the activity of NK cell.
Research report, active peptide can also promote the generation of tumor necrosis factor.
In some embodiments, the effect of the conditioning subhealthy state include be particularly suitable for small intestine occur functional disorder and
Postoperative patient is edible.
Black fungus active peptide can increase mucous membrane of small intestine height of naps, deepen Crypt depth, increase the absorbing surface of intestinal mucosa
Product promotes small intestine body of gland flourishing, increases the activity of amino acid peptase, therefore can promote the improvement of Small Intestinal.Small
When dysfunction occurs for intestines, the absorption function of active peptide is barely affected, and has high healthy nutritive value.In addition, art
The enteron aisle of patient is easy to be exposed under the infringement of pathogen afterwards, and active peptide can prevent pathogen from invading intestinal mucosa.
In some embodiments, the effect of the conditioning subhealthy state includes blood pressure lowering
Active peptide antihypertensive effect is steady, is not in the fluctuation in drug pressure reduction, is also depressured and endangers without drug
The side effect of other organs such as evil liver, kidney, has significantly more effect particularly with primary hypertension patient.
In some embodiments, the effect of the conditioning subhealthy state includes that buffering blood glucose rises
Active peptide is the effective component for constituting alpha-glucosidase inhibin.Contain a kind of alpha-glucosaccharase in human small intestine
Enzyme, major function are the various sugar that fast decoupled enters small intestine, supply demand of the human body to glucose.α-Portugal that active peptide is constituted
Polyglycoside enzyme inhibin, which has, to be prevented, alpha-glucosidase is delayed to make the degradation of the carbohydrate such as starch, sucrose, oligosaccharide
With, alleviate carbohydrate to glucose conversion, into blood, lead to blood glucose rise phenomenon, to reach reduction blood glucose target
Purpose, prevent Blood Glucose rise caused by complication.
In some embodiments, the effect of the conditioning subhealthy state includes anti-oxidant, anti-aging
Active peptide can be improved the activity of superoxide dismutase, glutathione peroxidase, anti-lipid peroxidation,
Scavenging hydroxyl advantageously reduces tissue oxidizing, protects body.Safeguard that cell eubolism, delaying cell aging make one to prolong
Year lengthens one's life.Accelerate damaged cell reparation simultaneously, keep human body vigor, reduce pigmented generation, to prevent and postpone the " longevity
Spot " appearance.
The another technical solution that the present invention takes is: a kind of medical usage of compound plant polypeptide, based on black fungus
Raw material is wanted, low temperature extracts complex polypeptide, is equipped with jujube and closes pharmaceutical preparation made from ginger extract, for adjusting sub-health population
Symptom, effectively improve sub-health status, enhance reserve, the resistance, restoring force of body, promote sub-health population to strong
Health conversion, prevents sub-health population from developing to disease direction.
In some embodiments, the effect of the conditioning subhealthy state includes antiallergy
Active peptide is the elderly that convalescent, digestive function decline, especially to the infant of cow milk protein allergy,
And easily cause food hypersenstivity people provide safety, without anaphylactoid nutrient protein source.
In some embodiments, the effect of the conditioning subhealthy state includes that accelerating alcohol decomposes, and reduces the murder by poisoning of alcohol
Effect
In some embodiments, the effect of the conditioning subhealthy state includes the alanine and leucine improved in blood
Content can effectively reduce the concentration of alcohol in blood under the collective effect of alanine and leucine, and accelerating alcohol decomposes,
Reduce the toxic action of alcohol.Leucine can make the alcohol for gathering brain tissue, reduce to the paralysis of bone and the work of abnormal contraction
With reducing the generation of the alcoholism phenomenon such as behavioral disorder, aphasia of alcohol user.
In some embodiments, the effect of the conditioning subhealthy state includes improving attention
The present invention uses biotechnology, and a kind of micromolecule polypeptide is extracted from black fungus cell, can increase cell membrane Na+, K
+-atpase activity is conducive to body synthesis ATP to cell energy and power is provided and promotes intraor extracellular mass exchange ability,
Accelerate metabolism, the acidic materials and superoxide radical accumulated in vivo are discharged, transfer cell viability, improves cellular sodium-potassium ATP
The activity of enzyme, it is anti-oxidant, comprehensive adjustment sub-health population psychosoma lack of proper care the stage fatigue, insomnia, etc. symptoms, promote inferior health to
Health conversion improves people's health level and quality of life.And raw material sources are extensive, integration of drinking and medicinal herbs, main composition
Using the black fungus complex polypeptide for the high-purity that black fungus is prepared by extraction, cooperate the concentrated extract of jujube and ginger
The resulting composition of mixing preparation has efficient booster action to the treatment of a variety of inferior health diseases, therefore has extremely good
Commercial promise.
Detailed description of the invention,
The Capillary Electrophoresis result for the compound protein enzymatic hydrolysis that the broken homogenate of Fig. 1 black fungus is generated by ferment
The molecular weight standard of Fig. 2 polypeptide
Fig. 3 standard molecular weight working curve
Fig. 4 albumen microwave acidolysis peptide-based gel permeation chromatography
Specific embodiment
The following examples are used to further illustrate the present invention, without that should limit the scope of the present invention:
Embodiment one: the preparation of black fungus polypeptide dry powder
1. taking 100 kilograms of black fungus, select, clean, is crushed in mechanical roller.It is added 5 times 55 DEG C of black fungus weight
Distilled water is crushed black fungus historrhexis and is homogenized 2 hours in high pressure homogenizer.
2. using 6.0mol/L HCl solution, pH value 5.5 is controlled.It is 5% according to substrate mass concentration, by aspergillus oryzae excision enzyme
Dosage 8%, Papain enzyme solution dosage 15%, under 55 DEG C of constant temperatures, aspergillus oryzae flavor enzyme dosage 5%, successively with being outer
Enzyme cutting effect 20 hours, Papain enzyme effect 60 hours, aspergillus oryzae flavor enzyme effect 10 hours.
3. being cooled to room temperature, 3000r/min is centrifuged 5 minutes, the enzyme deactivation 50 minutes of 70 DEG C of supernatant, is concentrated under reduced pressure, is obtained more
Peptide concentrate;55 DEG C of distilled water of 3-5 times of residual residue addition will be centrifuged, carry out 2 enzymic digestions, method and 2 phase of above step
Together.
(6) isolate and purify, with specific process, by small-molecular peptides liquid residual enzyme and other materials separate, small point
Sub- peptide liquid, which extracts, to be completed, and molecular weight is in 180 to 480 dalton.
(7) it is arranged with reverse osmosis concentration and removes moisture, become wet-milling, with the drying of microwave vacuum machine or is spray dried to do
Powder.
(8) particle of certain specification is made of granulator black fungus small molecule active peptide particles, is packed with vacuum packing machine
At required various quantitative packages.
4. step 3 gained concentrate is mixed well, it is spray-dried, granule or tablet, capsule is made;
5. the packaging of granule: 5g/ bags, 20 bags/box.
Usage and dosage: once in the morning and once at night, 1 bag every time, warm boiled water.
Two, of embodiment
Embodiment one: the preparation of black fungus polypeptide dry powder
1. taking 100 kilograms of black fungus, select, clean, is crushed in mechanical roller.It is added 5 times 55 DEG C of black fungus weight
Distilled water is crushed black fungus historrhexis and is homogenized 2 hours in high pressure homogenizer.
2. using 6.0mol/L HCl solution, pH value 5.5 is controlled.It is 5% according to substrate mass concentration, by aspergillus oryzae excision enzyme
Dosage 8%, Papain enzyme solution dosage 15%, under 55 DEG C of constant temperatures, aspergillus oryzae flavor enzyme dosage 5%, successively with being outer
Enzyme cutting effect 20 hours, Papain enzyme effect 60 hours, aspergillus oryzae flavor enzyme effect 10 hours.
3. being cooled to room temperature, 3000r/min is centrifuged 5 minutes, the enzyme deactivation 50 minutes of 70 DEG C of supernatant, is concentrated under reduced pressure, is obtained more
Peptide concentrate;55 DEG C of distilled water of 3-5 times of residual residue addition will be centrifuged, carry out 2 enzymic digestions, method and 2 phase of above step
Together.
(6) isolate and purify, with specific process, by small-molecular peptides liquid residual enzyme and other materials separate, small point
Sub- peptide liquid, which extracts, to be completed, and molecular weight is in 180 to 480 dalton.
(7) it is arranged with reverse osmosis concentration and removes moisture, become wet-milling, with the drying of microwave vacuum machine or is spray dried to do
Powder.
The detection of two, black fungus polypeptide of embodiment
1 materials and methods
The black fungus protein isolate homogenate of 1.1 raw materials and instrument embodiment one, protein content >=89%;Neutral protein
Enzyme, Wuxi bioengineering Co., Ltd of Jie Neng section avenge plum board (food-grade);Alkali protease, Wuxi Jie Neng section bioengineering have
Limit company avenges plum board (food-grade);Polypeptide molecular weight standard, Amersham Bio2sciences company, Capillary Electrophoresis are special
With;Micro-wave oven, lg electronics Electrical Appliances Co., Ltd, MS22089T;Formaldehyde, Xi'an chemical reagent factory are analyzed pure;Efficient capillary electricity
Swimming instrument, CE2212, Peking University's manufacture;Gel permeation chromatograph, 24142515, U.S. Waters.
1.2 test methods take 8g black fungus to separate homogenate, and 90g water is added, mixes well, and adjust solution ph to 8.0, are added
0.35g neutral proteinase, microwave 150W heat 1min, take out and cool down and supply moisture, place into microwave stove heating 1min, repeatedly
For several times, 40~45 DEG C of such temperature control, is heated repeatedly, and until pH value is constant, solution ph is 7.0 at this time;Adjust solution ph
To 3.5,0.3 g acid protease is added, microwave 150W heating, is heated repeatedly by 45~50 DEG C of temperature control, until pH value is constant,
PH value is 2~3 at this time;It takes out spare for detection.
Detection method
1. the detection of degree of hydrolysis and ammonia nitrogen is with formol titration (GB/T 14771-1993).The definition of degree of hydrolysis is original
The percentage that peptide bond is cleaved in material protein, formula are as follows: DH=h/htot × 100%=(CNH2/CSPIW)-C0NHI/
Htot × 100%;It is the peptide bond number of material protein that h, which is albumen is cleaved after hydrolyzing peptide bond number mmol/g, htot, in formula
mmol/g;It is a constant, black fungus albumen htot=8.8mmol/g for a certain specific protein htot;CNH2 is water
The content mmol/L, CSPIW for solving amino-acid nitrogen in protein liquid are the content mg/ml, C0NH2 of protein in hydrolyzed protein liquid
The content mmol/g of free amino nitrogen in material protein;To black fungus albumen, value is 0. 43mmol/g.
2. the detection of polypeptide surveys its molecular weight using Capillary Electrophoresis and gel permeation chromatography
The detection of 2 high performance capillary electrophoresis
1) detection of polypeptide.Protein breakdown object is dissolved in (5%22 sulfydryl second of 60mmol/L Tris/HCl+1%SDS+
Alcohol, pH value=6.0) mixed liquor in, set 5min in boiling water, be centrifugated 10 min (4 000r/min), supernatant is taken to pass through
0.45 μm of membrane filtration, sample introduction is analyzed after ultrasonic degassing.Quartz capillary respectively with distilled water, 0.1mol/L NaOH,
0.1mol/L HCl rinse 3min after, with buffer (100mmol/L Tris/HCl+0.1%SDS+0.1%PEO, pH value=
8.5) flushing is steady to baseline, sample running buffer 5min is not added, then 10 s of sample introduction in a manner of gas driven injection, is powered on
Press 10kV operation, cathode ultraviolet (214nm) detection.The result is shown in Figure 1.As can be seen from Figure 1: retention time 10.44,11.90,
13.22,14.19,14.70,16.16, there is peptide peak at 19.38min, and peak shape is independent, no trailing phenomenon illustrates separating effect
Well.
2. the determination of polypeptide molecular weight.Take Amersham Biosciences company polypeptide standard items by the above same method
Detection, is as a result shown in Fig. 2.Comparison diagram 1,2 can be seen that wherein 10.44,11.90min peptide peak be located at 2512Da or less, illustrate to decompose
It is lower than the small-molecular peptides of 2 512Da in object containing molecular weight;13.22,14.19min peptide peak is located at 2 512~6 214 base peaks,
Illustrate the peptide for being located at 2 512~6 214Da in decomposition product containing molecular weight;14.70,16.16min peptide peak is located at 6 214~8
159 base peaks illustrate the peptide for being located at 6 214~8 159Da in decomposition product containing molecular weight;19.38min peptide peak is located at 8 159
~10 700 base peaks, but close to 8 159 base peaks, illustrate the peptide for being greater than 8 159Da in decomposition product containing a small amount of molecular weight.
In addition the polypeptide molecular weight after black fungus soybean protein decomposes concentrates on 2 000~8 000.Divide greatly compared to protein
For son amount (100 000~600 000Da [6]), resulting polypeptide is within low molecular weight range.
3. gel permeation chromatography detects
3.1 gel infiltration instrument systems.2414 refractive index detection device (Refractive Index of Waters
Detector);515 geopressure gradients pump;7725i manual injector;Gel chromatographic columns: UltranydrogelTM Linear 7.8
×300mm column.Chromatographic condition: mobile phase 0.1M NaNO3,35 DEG C of column temperature, flow velocity 0.8ml/min.Standard sample: poly-
Molecular weight glycol standard (Ploycethylene gloycol Molecular Weight), place of production Polmer
Standards service2USA, range 106,194,440,628,960,1 460,4 290,7 130,12 900,20
600。
The production of 2 standard curves.Standard sample is configured to mobile phase
0.01% solution distinguishes sample introduction, after 0.45 μm of filtering with microporous membrane with the logarithm ln MW couple of standard molecular weight
Retention time mapping, can be obtained standard molecular weight working curve, such as Fig. 3.
3 sample tests.By protein,split high purity water soaked overnight, taken after 4 000r/min centrifuge separation
Clear liquid, through 0.45 μm of membrane filtration, sample introduction is analyzed after ultrasonic degassing, as a result sees Fig. 4.
By known to Fig. 3,4 controls, 25~40min occur 6 peptide peaks (40min with
Small molecule peak can not integrate out afterwards), it can be obtained with Millennium32 chromatographic work station integral, molecular weight is 12 respectively
826,3 735,1 389,945,481,121Da, and macromolecule molecule content is less, majority has concentrated on small-molecular-weight rank
Section, it is similar to capillary electrophoresis detection result.It should be the amino generated in hydrolytic process and with the presence of the molecule of more low molecular weight
Sour small molecule.It is heated using multiple, uninterrupted microwave, each 1min, protease will not be made to lose within the shorter time (15min)
It is living.
It is heated using multiple, uninterrupted microwave, every time 1
Min will not be such that protease inactivates within the shorter time (15min)
Three, black fungus polypeptide complex function of embodiment is for granule
30 parts of black fungus raw materials, 45 parts of jujube raw materials and 5 parts of ginger raw materials are taken, black fungus is made by by one method of embodiment
Polypeptide concentrate and jujube and ginger extract mix well, spray drying.It is with granulator that one gained black fungus of embodiment is small
The particle of certain specification is made in molecular activity peptide dry powder, and various quantitative packages required for being packaged into vacuum packing machine are made
Granula.
The packaging of granule: 5g/ bags, 20 bags/box.
Black fungus polypeptide complex function is for granule usage and dosage: once in the morning and once at night, 1 bag every time, warm boiled water.
The preparation of example IV black fungus polypeptide complex function oral solution
Take 20 parts of black fungus raw materials, 45 parts of jujube raw materials and 3 parts of ginger raw materials, the concentration of one gained black fungus polypeptide of embodiment
Liquid and jujube and ginger extract, which mix well, is sufficiently mixed allotment, emulsification, filling, pasteurization, dispatches from the factory after labeling.It will implement
One gained black fungus polypeptide concentrate of example and jujube and ginger extract mix well, and black fungus small-molecular peptides content is in 150mg/
100ml or more, product soluble solid 3.4g/100g or more.
The preparation of five, black fungus polypeptide complex function oral solution of embodiment
Take 40 parts of black fungus raw materials, 45 parts of jujube raw materials and 8 parts of ginger raw materials, the concentration of one gained black fungus polypeptide of embodiment
Liquid and jujube and ginger extract, which mix well, is sufficiently mixed allotment, emulsification, filling, pasteurization, dispatches from the factory after labeling.It will implement
One gained black fungus polypeptide concentrate of example and jujube and ginger extract mix well, and black fungus small-molecular peptides content is in 150mg/
100ml or more, product soluble solid 3.4g/100g or more.
The functional verification of the black fungus polypeptide complex function oral solution of six, example IV of embodiment
1. restoring physical efficiency and mitigating the verification test for moving caused muscle damage
Crowd's grouping: 60 normal adults of validation group, 25~40 one full year of life, male 30, female 30,40 people of control group, 25
~40 one full year of life, male 20, female 30.
Test method: 60 normal adults of validation group and 40 people of control group participate in the running of 50000 meters of same field respectively, than
Pre-games validation group takes the drinks of embodiment, and control group does not take the drinks.After 2 myriametres, verifying race is still able to maintain
Former speed is advanced, and it is to slow down that the Athletess speed of control group, which is opened,.Validation group 58 people of agent after end of match damages without muscle
Resulting myalgia, swelling feeling are injured, 2 people have the slight swollen feeling of acid;38 people of control group feels severe to moderate flesh
Meat pain, swelling.
The result shows that before movement, in movement, supply active peptide can provide sufficient energy to body, be able to suppress flesh
The decline of meat strength maintains abundant physical strength for a long time.
2. eliminating the verification test of brain fag
Crowd's grouping: 60 normal adults of validation group, 25~40 one full year of life, male 30, female 30,40 people of control group, 25
~40 one full year of life, male 20, female 30.
Test method: 60 normal adults of validation group and 40 people of control group are arranged to be involved in reading 4 hours, validation group exists
The drinks of embodiment are taken before reading, control group does not take the drinks.After 4 hours read, validation group is detected
The rising of the blood oxidation hemoglobin concentration of 40 people of 60 normal adults and control group.As a result, 60 health of validation group at
Year, people only had the blood oxidation hemoglobin ratio of 5 people to rise 1~3%, and 40 normal adults of control group have 35 blood oxygen
Change hemoglobin ratio and rises 20~30%.
3. the verification test for hindering fat absorption, accelerating lipolysis, promoting basic metabolism
Crowd's grouping: 60 obese adults of validation group, 25~40 one full year of life, male 30, female 30,40 obesities of control group
Adult, 25~40 one full year of life, male 20, female 20.
Test method: 60 normal adults of validation group and 40 people of control group are arranged to be involved in and take test, daily
The drinks of 200mL embodiment replace lunch, and control group does not take the drinks.After 3 months, 56 people of validation group is fat
Figure is significant, and control group does not have change.
4. adjusting the verifying of blood lipid, norcholesterol function
Male mice 60 are taken, is randomly divided into 6 groups by weight, every group 10, respectively Normal group, model group, tool
Body embodiment 1-4.
Normal group, feed common distilled water;
Model group, feeding high lipid food (1% cholesterol, 0.5% Pig cholate, 12% lard, basal feed 86.5%) are fed
It supports;
Model group gives deep sea fish oil (5mg/kg), twice daily, 2 milliliters every time;
Specific embodiment 1-4 feeds high lipid food (1% cholesterol, 0.5% Pig cholate, 12% lard, basal feed
86.5%) it feeds;
Specific embodiment 1-5 group is fed specific embodiment 1-4 content (5mg/kg), twice daily, 2 milliliters every time;
It is continuous to feed 3 weeks.
Once a day, successive administration 21 days, 1.5h (fasting 12h), mouse pluck eyeball and take blood after the last administration, separate blood
Clearly, TG, TC are surveyed with kit method.
Statistical analysis
All experimental datas are indicated with mean ± SD, are examined using t and are carried out statistical analysis, and p < 0.05 thinks there is system
Meter learns difference.
Experimental result
Statistical analysis
All experimental datas are indicated with mean ± SD, are examined using t and are carried out statistical analysis, and p < 0.05 thinks there is system
Meter learns difference.
Experimental result
Group | TC(mmol/L) | TG(mmol/L) |
Validation group | 2.85±0.12 | 1.28±0.23 |
Model group | 4.23±0.28 | 2.81±0.21 |
Example 1 group | 3.90±0.29** | 1.91±0.31** |
2 groups of embodiment | 3.83±0.32* | 1.85±0.13* |
3 groups of embodiment | 3.82±0.51** | 1.62±0.35** |
Embodiment 4 | 3.72±0.30** | 1.52±0.22** |
#Normal group of P < 0.01vs;* P < 0.05, * * P < 0.01vs model group
Brief summary:
The content of specific embodiment 1-4 can significantly reduce the content of total cholesterol (TC) and triglycerides (TG), and
Sharing for content component has synergistic function in specific embodiment 4.
5. improving the verifying of immunity function to functions of murine peritoneal macrophages/active influence)
Test animal: experimental animal is kunming mice, half male and half female, 18~22 grams of weight.
Experiment is taken to be randomly divided into 4 groups with kunming mice, blank group daily diet, gives tested products by 3 groups of experimental group
(composition of embodiment 1-3 preparation), after being administered daily 2 times, 10 days, in 30 minutes after the last administration, (blank group was after feeding
30 minutes), 6% chicken erythrocyte suspension 1.5ml/ of each group mouse peritoneal injection only, extracts mouse peritoneal liquid, sees under microscope
Examine, macrophage swallows chicken red blood cell number in the visual field in record 5 minutes, and with formula: phagocytic percentage=swallowed is red thin
Erythrocytes × 100% in born of the same parents' number/visual field;Macrophage in the Erythrocytes/visual field for phagocytic index=swallowed
Number.Phagocytic percentage is calculated, experimental result see the table below.
The influence of functions of murine peritoneal macrophages
Two groups of curative effects of table compare
Group | Phagocytic percentage | Phagocytic index |
Blank group | 25.2±3.89 | 0.41±0.15 |
Example 1 group | 46.4±5.13 | 0.62±0.13 |
2 groups of embodiment | 49.7±4.65 | 0.69±0.35 |
3 groups of embodiment | 52.9±6.25 | 0.72±0.23 |
It can be seen that the mouse of experimental group after drug of the present invention is used continuously from upper table data, the total of macrophage must
To enhancing by a small margin, while the activity of macrophage is remarkably enhanced, it is seen that pharmaceutical composition of the invention has good
The effect of good resistance building.
6. buffering the functional verification that blood glucose rises
In vivo evaluation
After buying the male SD system big white mouse (CHARLES RIVER company) of 7 weeks sizes, the preparation raising carried out 1 week (is raised
Material is subsequently used for testing with MF particle (yeast society of Japan manufactures).
1 obtained active peptide composition (20mg/ml) of embodiment is dissolved in deionized water 1ml, sample solution is made,
With feeding tube, the oral big white mouse stomach being sent into after going on a hunger strike 16 hours.After five minutes, saccharic (maltose is orally put by force
2g/kg), it takes a blood sample after 0 point, 30 points, 60 points and 120 minutes from tail vein after saccharic load.By obtained blood at once into
Promoting circulation of blood sugar determination (glucose tests PRO, three and chemistry institute).And control group then replaces propolis solution with water.
The effect for inhibiting blood glucose rise is to measure glucose amount in blood according to different periods, compares blood glucose rise area
(AUC) judge.Blood glucose rise area calculates according to the following formula:
AUC(h*Mg/dl)=(a+2b+3c+4d)/4-2a
A, b, c and d in above formula, the blood glucose value after meaning 0 point, 30 points, 60 points and 120 minutes respectively.
Numerical value indicates that effectively poor measurement between 2 groups is examined according to the t of Student and carried out with average value ± standard deviation.
The results are shown in Table 3.N in table indicates sample number.In table and figure**Indicate with less than 1% level of significance with it is right
It is effective poor to compare according to group.
Table 3
With in saccharic load only with the control group of water compared with, 50% methanol of propolis is molten to be had effectively really from component
Inhibition blood glucose rise effect, which can effectively continue to saccharic load after sixty minutes, and for AUC, and control group is
130.7±8.3h*Mg/dl, 50% methanol is molten is divided into 80.7 ± 4.2h from group*mg/dl.Compared according to the AUC, blood glucose rise suppression
Rate processed is 38.3%.
7. active peptide has feritin inhibitory activity and ACE inhibitory activity to the verifying ACE with antihypertensive function simultaneously
Inhibitory activity detection method is as follows: 1mL 0.5mM FAPGG (full name N- [3- (2-Furyl) being added in cuvette
Acryloyl]-L-phenylalanyl-glycyl-glycine) (it is dissolved in 50mM Tris-HCl buffer, contains 0.3M
NaCl, pH 7.5), 20 μ L ACE (1U/mL, final vigor 20mU), (albumen is dense for 200 μ L blood pressure lowering black fungus activity peptide solutions
Degree is 1mg/mL;Solvent is 50mM Tris-HCl buffer, NaCl containing 0.3M, pH 7.5), it mixes at room temperature, is surveyed in 2min
Determine the reduction rate blank of light absorption value under 345nm and replaces sample to calculate ACE suppression according to the following formula with Tris-HCl buffer
System activity:
ACE inhibitory activity (%)=1- [△ A.min-1 (sample)/△A.min-1 (blank)] × 100%,
Wherein, △ A.min-1 (sample)With △ A.min-1 (blank)It is the ACE activity suppression rate for indicating sample and blank respectively.
The detection method of feritin inhibitory activity is as follows: blood pressure lowering vegetable seed black fungus active peptide inhibits angiotensins active
External test according to renin activity kit (purchase in Cayman Chemical, number 10006270) providing method, press with
Lower step measurement: (1) blank: 20 μ L substrates, 160 μ L test buffer, 10 μ L pure water are sequentially added in 96- orifice plate;(2) empty
White control: 20 μ L substrates, 150 μ L test buffer, and 10 μ L pure water;(3) sample: 20 μ L substrates, 150 μ L test are used slow
Fliud flushing, and 10 μ L samples.The starting reaction of 10 μ L feritins is added in each hole (in addition to blank) respectively later.96- orifice plate room temperature
Lower concussion 10s, preheats 15min at 37 DEG C, and the fluorescence intensity of sample, excitation wavelength 340nm, transmitted wave are measured in 10min
Long 490nm calculates the feritin inhibitory activity of sample according to the following formula:
Wherein, 100% suppression speed (blank
Control) and suppression speed (sample) be the renin activity suppression speed for indicating blank control and sample in 10min respectively.Wherein
The test preparation of buffer: (1) buffer: 50mM Tris-HCl buffer, NaCl containing 0.1M, pH 8.0 is prepared;(2) will
Blood pressure lowering vegetable seed active peptide is dissolved in the buffer, and the solution that protein concentration is 1mg/mL is made, and buffer is used in as test.
Inhibited using the ACE inhibitory activity 50.84% of the blood pressure lowering vegetable seed black fungus active peptide of above method preparation, feritin
Activity 75.31%, has a good application prospect in terms of blood pressure lowering.
8. the functional verification of resisting oxidation and delaying senility
Anti-oxidant experiment:
In order to verify whether product of the invention has oxidation resistant functionality, 1 sample of sample selection example of the present invention
Clinical test is carried out, test process is as follows.
100 40~60 years old ages of study subject, health volunteer test.
Detection method:
Experimental group: 50 volunteers are daily test-manufactured by recommendation instructions of taking (daily 2,2 times a day), dose
Product;
Control group: in addition 50 volunteers take placebo (vitamin E) as a control group.
Continuously take 30 days.All subjects adhere to primary work during test, and diet is constant.It is tested after test
The content that subject takes malonaldehyde, superoxide dismutase and glutathione peroxidase in the blood of front and back is carried out pair
Than.
Table 1: the testing result table of MDA, SOD and GSH-Px level in serum
Note: compared with before test-meal,aP < 0.05;Compared with the control group,bP < 0.05.
As can be known from the results of Table 1: 50 volunteers sera's malonaldehyde, superoxide dismutase and the paddy Guangs for taking placebo
The contents level of sweet peptide peroxidase is without significant change;SOD vigor is significantly raised in test-meal group serum after test, with the same period pair
According to relatively, difference is statistically significant (P < 0.05) before group and itself test.In addition, all volunteers during the test and
After the test in 6 months, do not occur influencing the reaction of body health.The composition of comprehensive judgement the present embodiment 1 has anti-
Oxidative function.
Delay senescence test:
In order to verify the functionality whether product of the invention has anti-aging, sample of the present invention carries out human clinical's survey
Examination, test process are as follows:
Skin dimness, coarse 30~50 years old women, 70 people are chosen, is divided into invention group and control group at random, control group is adopted
With commercially available common natural vitamin E soft capsule, invention group uses the product composition of embodiment 1.
Application method are as follows: pressure contracting face paper is immersed in clear water and impregnated, and soft capsule is punctured, liquid in soft capsule is instilled
In clear water, face paper is impregnated 5 minutes in the mixed liquor of clear water and flexible glue capsule-core liquid then, takes out face paper, opening is applied
On the face, face paper is removed after 15 minutes, is cleaned face with warm water, once a night.The shield of other faces used in every group of experimenter
Skin condition is same, adheres to that primary work, diet are constant.After 30 days, control group have the facial skin of 18 people relatively using it is preceding it is fine and smooth,
Bleach and glossy, invention group have the facial skin of 26 people compared with using it is preceding it is fine and smooth, bleach and glossy.It follows that of the invention
Resulting composition can improve skin tone, delay senescence, and effect is significantly better than existing commercially available common natural VE flexible glue
Capsule.In addition, all volunteers during the test and after the test in 6 months, do not occur influencing the reaction of body health,
It can be using the health care product with preparation for anti-oxidant anti-aging.
9. the functional verification that accelerating alcohol decomposes --- improve for expiration alcohol concentration
Divided 2 times with 6 average age 28 years old male people and tested, each trial interval is greater than 72 hours.Experiment 4:
On an empty stomach, 42 degree of white wine 90ml are drunk, drink pure water 300ml before wine.
Experiment 5: on an empty stomach, 42 degree of white wine 90ml is drunk, the formula is drunk before wine and sobers up and drink 300ml.
Experiment 6: on an empty stomach, 42 degree of white wine 90ml are drunk, drink, which is chatted with the black fungus active peptide function one of embodiment with you, before wine is
Main Anti-alcohol beverage 300ml.
Conclusion: the formula has improvement result to alcohol breath concentration, i.e., has facilitation to alcohol dehydrogenase activity,
Ethanol decomposition efficiency can effectively be promoted.
The formula has excitation alcohol dehydrogenase, aldehyde dehydrogenase activity after can finally drinking by molten water, improve simultaneously
Constitution, thus the function of Soboring-up liver-protecting.
10. improving the functional verification of attention
The clinical observation of present composition intervention attention
It collects 20 readme attentions and is difficult to the adult concentrated, the age is between 19-50 years old.Using Shu Er special formula lattice amount
Table assesses volunteer's attention, and is divided into 2 groups immediately by attention, and 1 group is treatment group, and 2 groups are control group.Treatment group suffers from
The daily edible nourishing of person pastes 30g, wherein the present composition prepared in embodiment 3 ratio in nutrition paste is 16%.Control
Group gives the paste of the nutrition without present composition 30g.Nutrition paste is made of red bean, corn etc..After volunteer is 1 month edible again
It is secondary that attention force estimation is carried out using scale.As a result such as table 2.
Clinical observation of 2 present composition of table to attention is intervened
Note: compared with the control group: * P < 0.05;* P < 0.01
Experimental result: the edible nutrition paste containing 16% present composition is remarkably improved absent minded crowd
Attention scale score, it was demonstrated that the present composition, which has, preferable improves attention effect.
Claims (9)
1. a kind of function edible composition, characterized in that described comprising black fungus polypeptide, Ginger P.E and Fructus Jujubae extract
Black fungus polypeptide derives from black fungus raw material, and the Ginger P.E derives from ginger raw material, and the Fructus Jujubae extract derives from
Jujube raw material.
2. function edible composition according to claim 1, characterized in that the black fungus raw material, ginger raw material and big
The weight ratio of jujube raw material is 20~40 parts: 30~60 parts: 3~10.
3. function edible composition according to claim 1, characterized in that the black fungus polypeptide, Fructus Jujubae extract and
The weight ratio of Ginger P.E is 30 parts: 45 parts: 4~6 parts.
4. the preparation method of the described in any item function edible compositions of claims 1 to 3, characterized in that comprising steps of
(1) black fungus small-molecular peptides solution is prepared;
(2) jujube and ginger mixed extract are prepared;
(3) by black fungus small-molecular peptides solution, jujube extracting solution and ginger extract according to 10~20 parts: 30~60 parts: 5~10
Weight ratio mixing preparation;
(4) mixture drying is formed into powder mixture.
(5) using step (4) resulting powder mixture as additive, function edible composition is prepared.
5. the preparation method of function edible composition according to claim 4, characterized in that
(1) prepare black fungus small-molecular peptides solution comprising steps of
Pre-treatment:
A pyrohydrolysis;
B homogenate;
C sterilizing;
Digest black fungus polypeptide:
D is added compound protease and decomposes;
E centrifugation, separates the proteases for decomposing object of black fungus;
(2) prepare jujube and ginger mixed extract include be respectively washed, jujube and ginger, impregnate, decocting, filtering is dense
It is reduced to the concentrate that specific gravity is 1.25~1.38;
(3) include by black fungus complex polypeptide concentrate and 10~20 parts: 30 in parts by weight of jujube, ginger concentrate~
60 parts: 5~10 of parts by weight mix, and spray drying forms mixture dry powder,
Drying in (4) includes that spray drying or reduced vacuum are dry.
6. the preparation method of function edible composition according to claim 5, characterized in that the proteinase complex includes
Albumen excision enzyme, protein incision enzyme and food flavor enzyme, the albumen excision enzyme, protein incision enzyme and food flavor enzyme.
7. the preparation method of function edible composition according to claim 5, characterized in that the proteinase complex is by wood
Melon restriction endonuclease and yeast flavor enzyme composition.
8. the preparation method of function edible composition according to claim 7, characterized in that the proteinase complex is by egg
Ultrawhite enzyme cutting and protein incision enzyme composition, the albumen excision enzyme, protein incision enzyme composition ratio are 1:10~10:11 or excellent
Select 1:5`5:1, or more preferably 1:2~2:1.
9. function edible composition according to claims 1 to 8, characterized in that the function edible composition include but
It is not limited to capsule, lozenge, drink with function and biscuit.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811091421.4A CN109275914A (en) | 2018-09-19 | 2018-09-19 | Black fungus polypeptide function edible composition and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811091421.4A CN109275914A (en) | 2018-09-19 | 2018-09-19 | Black fungus polypeptide function edible composition and its preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109275914A true CN109275914A (en) | 2019-01-29 |
Family
ID=65180802
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811091421.4A Withdrawn CN109275914A (en) | 2018-09-19 | 2018-09-19 | Black fungus polypeptide function edible composition and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109275914A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112715926A (en) * | 2020-10-28 | 2021-04-30 | 陕西秦巴神仙叶食品有限公司 | Preparation method of immortal leaf and black fungus oligopeptide |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN88101423A (en) * | 1987-03-20 | 1988-10-05 | 制铁化学工业株式会社 | Edible composition |
CN101569690A (en) * | 2009-05-08 | 2009-11-04 | 迟淼 | Preparation method for compound plant polypeptide and medicinal application thereof |
CN102038074A (en) * | 2010-12-18 | 2011-05-04 | 胡保军 | Process for extracting agaric collagen |
CN103397067A (en) * | 2013-07-26 | 2013-11-20 | 伊春市天隆农林发展有限公司 | Technology for extraction of edible fungus collagen |
CN104397320A (en) * | 2014-12-06 | 2015-03-11 | 黑龙江众生生物工程有限公司 | Extraction method of black fungus collagen |
CN107638560A (en) * | 2017-07-25 | 2018-01-30 | 赵德润 | A kind of preparation method of edible fungi active peptide |
CN107736538A (en) * | 2017-10-13 | 2018-02-27 | 唐山十三肽保生物工程技术有限公司 | A kind of black fungus small-molecular peptides solid beverage and preparation method thereof |
-
2018
- 2018-09-19 CN CN201811091421.4A patent/CN109275914A/en not_active Withdrawn
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN88101423A (en) * | 1987-03-20 | 1988-10-05 | 制铁化学工业株式会社 | Edible composition |
CN101569690A (en) * | 2009-05-08 | 2009-11-04 | 迟淼 | Preparation method for compound plant polypeptide and medicinal application thereof |
CN102038074A (en) * | 2010-12-18 | 2011-05-04 | 胡保军 | Process for extracting agaric collagen |
CN103397067A (en) * | 2013-07-26 | 2013-11-20 | 伊春市天隆农林发展有限公司 | Technology for extraction of edible fungus collagen |
CN104397320A (en) * | 2014-12-06 | 2015-03-11 | 黑龙江众生生物工程有限公司 | Extraction method of black fungus collagen |
CN107638560A (en) * | 2017-07-25 | 2018-01-30 | 赵德润 | A kind of preparation method of edible fungi active peptide |
CN107736538A (en) * | 2017-10-13 | 2018-02-27 | 唐山十三肽保生物工程技术有限公司 | A kind of black fungus small-molecular peptides solid beverage and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112715926A (en) * | 2020-10-28 | 2021-04-30 | 陕西秦巴神仙叶食品有限公司 | Preparation method of immortal leaf and black fungus oligopeptide |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104824548B (en) | Matrimony vine compound health ferment and preparation method thereof | |
CN104473249B (en) | A kind of liquid preparation of Pollen Pini and preparation method thereof | |
CN103054113B (en) | Composite fruit-vegetable juice beverage with blood sugar decreasing effect | |
AU2020100782A4 (en) | Red food comprising composite small molecule peptides and use thereof in repairing oxidative damage of organism | |
CN106798252A (en) | A kind of natto prescription with coordinating intestines and stomach reducing blood lipid thrombus dissolving effect | |
WO2020052074A1 (en) | Extract for improving liver detoxification, dispelling alcohol and protecting liver, and preparation method therefor | |
CN101664180B (en) | Health-care nutritional complexing agent with health effect and preparation method thereof | |
GB2589967A (en) | Chinese yellow rice wine containing ingredients of mulberry leaves (morus alba L.) and silkworm pupae (bombyx mori) and production method thereof | |
CN106418525A (en) | Fermenting folium mori chewable tablet and preparation method thereof | |
CN102499291B (en) | Milk powder with functions of maintaining beauty and keeping young and improving immunity of organism and preparation method thereof | |
CN106616947A (en) | Cordyceps militaris composition | |
CN106343567A (en) | Noni oral liquid and preparing method thereof | |
CN109527190A (en) | The preparation method and applications of the compound small molecule Gly-His-Lys of black fungus | |
CN110710678A (en) | Marine polypeptide donkey-hide gelatin paste capable of nourishing liver and kidney, nourishing blood and soothing nerves and preparation method thereof | |
KR20100079269A (en) | Anticancer health foods including fermented ginseng with mushroom | |
KR20210063657A (en) | A natural tea removing the effect of hangover contained the extract material in Hovenia dulcis and a cactus | |
CN113455602A (en) | Plant enzyme peptide beverage and preparation method thereof | |
CN108244654A (en) | Caterpillar fungus nutritire breakfast flour | |
CN116898098A (en) | Boletus peptide anti-alcoholic formula and raw material preparation method | |
CN106924548A (en) | The medicine and preparation method of a kind of fatigue-relieving | |
CN104739964B (en) | A kind of snail sobering preparation and preparation method thereof | |
CN109275914A (en) | Black fungus polypeptide function edible composition and its preparation method and application | |
KR20110118911A (en) | Lactic acid bacteria fermented extract using cereals and herb medicine materials, and method of preparing thereof | |
CN107822122A (en) | A kind of rhodiola root ferment and preparation method thereof | |
CN112076292A (en) | Powder with functions of enhancing immunity and regulating kidney yin deficiency and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190129 |
|
WW01 | Invention patent application withdrawn after publication |